These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6438690)

  • 1. Assessment of symptom change from improvement curves on the Hamilton depression scale in trials with antidepressants.
    Bech P; Allerup P; Reisby N; Gram LF
    Psychopharmacology (Berl); 1984; 84(2):276-81. PubMed ID: 6438690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Hamilton depression scale. Evaluation of objectivity using logistic models.
    Bech P; Allerup P; Gram LF; Reisby N; Rosenberg R; Jacobsen O; Nagy A
    Acta Psychiatr Scand; 1981 Mar; 63(3):290-9. PubMed ID: 7015793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerance of femoxetine and imipramine in the treatment of depressive states. A randomized, double-blind study.
    Suominen J; Tamminen T; Elosuo R; Manniche PM
    Pharmacopsychiatry; 1988 Sep; 21(5):238-44. PubMed ID: 3067246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The WHO Depression Scale. Relationship to the Newcastle Scales.
    Bech P; Gram LF; Reisby N; Rafaelsen OJ
    Acta Psychiatr Scand; 1980 Aug; 62(2):140-53. PubMed ID: 7468286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
    Schweizer E; Feighner J; Mandos LA; Rickels K
    J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can mildly depressed outpatients with atypical depression benefit from antidepressants?
    Stewart JW; McGrath PJ; Quitkin FM
    Am J Psychiatry; 1992 May; 149(5):615-9. PubMed ID: 1575250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Danish University Antidepressant Group.
    Psychopharmacology (Berl); 1986; 90(1):131-8. PubMed ID: 2876451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fengabine, a new GABAmimetic agent in the treatment of depressive disorders: an overview of six double-blind studies versus tricyclics.
    Magni G; Garreau M; Orofiamma B; Palminteri R
    Neuropsychobiology; 1989; 20(3):126-31. PubMed ID: 2668780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minaprine and dose response in depression. An investigation of two fixed doses of minaprine compared with imipramine.
    Montgomery SA; Baldwin DS; Priest RG; Steinert J; Patel A; Herrington RN; Livingston HM
    Pharmacopsychiatry; 1991 Sep; 24(5):168-74. PubMed ID: 1775522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of imipramine in psychotic versus nonpsychotic depression.
    Birkenhager TK; van den Broek WW; Mulder PG; Moleman P; Bruijn JA
    J Clin Psychopharmacol; 2008 Apr; 28(2):166-70. PubMed ID: 18344726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in subjective work performance after treatment of chronic depression: some preliminary results. Chronic Depression Study Group.
    Finkelstein SN; Berndt ER; Greenberg PE; Parsley RA; Russell JM; Keller MB
    Psychopharmacol Bull; 1996; 32(1):33-40. PubMed ID: 8927672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP; Boyer WF
    J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy issues with antidepressants.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1997; 58 Suppl 6():32-9. PubMed ID: 9227671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary MHPG is not a good predictor of antidepressive drug response.
    Puzyński S; Rode A; Bidziński A; Mrozek S; Załuska M
    Pol J Pharmacol Pharm; 1984; 36(4):329-35. PubMed ID: 6527968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.
    Fabre LF
    J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A placebo- and imipramine-controlled study of paroxetine.
    Cohn JB; Crowder JE; Wilcox CS; Ryan PJ
    Psychopharmacol Bull; 1990; 26(2):185-9. PubMed ID: 2146697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distal colon motility as a predictor of antidepressant response to fenfluramine, imipramine and clomipramine.
    Lechin F; Van der Dijs B; Gómez F; Arocha L; Acosta E; Lechin E
    J Affect Disord; 1983 Feb; 5(1):27-35. PubMed ID: 6220041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
    Fawcett J; Marcus RN; Anton SF; O'Brien K; Schwiderski U
    J Clin Psychiatry; 1995; 56 Suppl 6():37-42. PubMed ID: 7649972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of Hydiphen in the treatment of endogenous depression].
    Nowakowska C; Chłopocka-Woźniak M; Strzyzewski W
    Psychiatr Pol; 1989; 23(1):10-7. PubMed ID: 2682710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.